Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi SDAX UCITS ETF Dist

C005 · LU2611732475 · class UCITS ETF Dist · EUR · domicile Luxembourg
Equity · EurozoneSFDR art. 6
Index tracked: Deutsche Borse SDAX Performance Index
TER
0.70%+ trans. 0.19%
Fund size
165 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Distributingannual
Launch 7 Dec 2023 · costs from the KID as of 2 Sept 2026 · 72 securities held · 8 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The Sub-Fund is an index-tracking UCITS passively managed. The objective of this Sub-Fund is to track the performance of the SDAX Total Return Index (the “Index”), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index: dividends net of tax paid by the Index constituents are included in the Index return. The Index is the selection index…

Performance since series start (in euro) — base 100

29 Nov 20238 Sept 2026 · dividends reinvested where declared by the issuer
20242025202614399139
High 143 (29 May 2026) · low 99 (6 Nov 2024) · last 139. Past performance is not indicative of future results.

Returns in euro

1 year+13.4%
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start+39.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)17.48%17.48%
Max drawdown−11.85%−11.85%
Sharpe0.510.51
Sortino0.730.73
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C005 · LU26117324751
RebalixC005 · LU2611732475 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
YearFundIndexTD
2025+24.55%+25.26%−0.71%

Distributions · per share, in EUR

Frequency: annual · last 12 months: 1.96 EUR (1.35% of NAV) · last ex-date 9 Dec 2025
YearPaymentsTotal (EUR)Dividend yield
202511.96+1.81%
202412.28+2.01%
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 72 securities · top-10 weight = 27.8%
Top holdingsWeight
JUNGHEINRICH NON VTG PRF DM503.0%
BEFESA SA3.0%
ALZCHEM GROUP AG3.0%
SMA SOLAR TECHNOLOGY AG2.9%
CARL ZEISS MEDITEC AG2.9%
STROEER SE & CO KGAA2.9%
TEAMVIEWER SE2.8%
REDCARE PHARMACY NV2.5%
SAF-HOLLAND SE2.4%
JOST WERKE SE2.4%
Countries (% of fund)
Germany100.0%
Sectors (% of fund)
Industrials31.8%Information Technology16.9%Health Care12.9%Consumer Discretionary10.0%Consumer Staples6.9%

Listing venues

ESMA register (FIRDS) and official exchange lists
C005 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 17 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU2611732475/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU2611732475/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU2611732475/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU2611732475
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · C005 · LU26117324752